Announce Date | 05/09/2025 |
EPS Normalized Actual | $0.23 In Line |
EPS GAAP Actual | $0.23 In Line |
Revenue Actual | $0.74407B |
Revenue Surprise | Beat by $744.07M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.65 |
EPS GAAP Estimate | $0.65 |
Revenue Estimate | $0.981797747B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 1.1876 | 9.25 | 1.12223 | 1.26829 | 1 |
Dec 2028 | 1.68 | 6.54 | 1.65101 | 1.70899 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.15 | -0.26 | 0.74407B | -20.57% | -1418.97M |
FQ4 2024 (Dec 2024) | -0.54 | -0.54 | 0.486949B | -97.42% | 486.95M |
FQ3 2024 (Sep 2024) | -0.91 | -0.91 | 0.938383B | 3.89% | 938.38M |
FQ2 2024 (Jun 2024) | -11.74 | -11.74 | 0.89736B | 0.19% | 897.36M |
FQ1 2024 (Mar 2024) | 0.38 | 0.38 | 0.897158B | -3.46% | 897.16M |
FQ4 2023 (Dec 2023) | 0.45 | 0.45 | 0.961351B | -6.01% | 961.35M |
FQ3 2023 (Sep 2023) | 0.37 | 0.37 | 0.901873B | -15.56% | 901.87M |
FQ2 2023 (Jun 2023) | 0.5 | 0.5 | 0.895685B | 0.01% | 895.69M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.65
Consensus Revenue Estimates
0.981797747B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | -2.6067 | -- | -2.6067 | -2.6067 | 1 |
FQ3 2027 (Sep 2027) | 1.0428 | -- | 1.0428 | 1.0428 | 1 |
FQ2 2027 (Jun 2027) | 1.99 | -- | 1.99 | 1.99 | 1 |
FQ1 2027 (Mar 2027) | 2.8544 | -- | 2.8544 | 2.8544 | 1 |
FQ4 2026 (Dec 2026) | -2.7272 | -- | -2.7272 | -2.7272 | 1 |
FQ3 2026 (Sep 2026) | 1.0129 | -- | 1.0129 | 1.0129 | 1 |
FQ2 2026 (Jun 2026) | 1.993 | -- | 1.993 | 1.993 | 1 |
FQ1 2026 (Mar 2026) | 2.7524 | 94.55 | 2.7524 | 2.7524 | 1 |
FQ4 2025 (Oct 2025) | 0.87 | 162.07 | 0.87 | 0.87 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.19B | -- | 1.19B | 1.19B | 1 |
FQ3 2027 (Sep 2027) | 1.17B | -- | 1.17B | 1.17B | 1 |
FQ2 2027 (Jun 2027) | 1.14B | -- | 1.14B | 1.14B | 1 |
FQ1 2027 (Mar 2027) | 1.12B | -- | 1.12B | 1.12B | 1 |
FQ4 2026 (Dec 2026) | 1.1B | -- | 1.1B | 1.1B | 1 |
FQ3 2026 (Sep 2026) | 1.08B | -- | 1.08B | 1.08B | 1 |
FQ2 2026 (Jun 2026) | 1.06B | -- | 1.06B | 1.06B | 1 |
FQ1 2026 (Mar 2026) | 1.05B | 28.84 | 1.05B | 1.05B | 1 |
FQ4 2025 (Oct 2025) | 1B | 51.29 | 1B | 1B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.41 | 0.15 | -0.26 | -173.33% |
FQ4 2024 (Dec 2024) | -0.54 | -0.54 | 100% | |
FQ3 2024 (Sep 2024) | -0.91 | -0.91 | 100% | |
FQ2 2024 (Jun 2024) | -11.74 | -11.74 | 100% | |
FQ1 2024 (Mar 2024) | 0.38 | 0.38 | 100% | |
FQ4 2023 (Dec 2023) | 0.45 | 0.45 | 100% | |
FQ3 2023 (Sep 2023) | 0.37 | 0.37 | 100% | |
FQ2 2023 (Jun 2023) | 0.5 | 0.5 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $2.16B | $0.74B | $-1418.97M | -190.7% |
FQ4 2024 (Dec 2024) | $0B | $0.49B | $486.95M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.94B | $938.38M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.9B | $897.36M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.9B | $897.16M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.96B | $961.35M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.9B | $901.87M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.9B | $895.69M | 100% |